Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesTargeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes, Published online: 28 November 2017; doi:10.1038/nrclinonc.2017.188Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research